20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation.

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A low intake of Fermentable, Oligo-, Di-, Mono-saccharides and Polyols (FODMAPs) is effective in the symptom control of irritable bowel syndrome (IBS) patients but may exert negative effects on the intestinal microbiota. The microbial effects of increasing regular or non-FODMAP fibre sources are largely unknown. Furthermore, it is not known if the baseline microbiota composition is associated with individual symptom control during the consumption of different rye products in IBS patients. Our objective was to evaluate whether increased consumption of low-FODMAP rye bread or regular rye bread for 4 weeks would alter the intestinal microbiota composition of IBS patients following their habitual diet, and whether these changes associate to symptoms and/or the baseline microbiota.

          Related collections

          Author and article information

          Journal
          BMC Nutr
          BMC nutrition
          Springer Science and Business Media LLC
          2055-0928
          2055-0928
          2019
          : 5
          Affiliations
          [1 ] 1Faculty of Medicine, Pharmacology, Medical Nutrition Physiology, University of Helsinki, Helsinki, Finland.
          [2 ] 2Aava Medical Centre, Helsinki, Finland.
          [3 ] Booston Oy Ltd, Viikinkaari 6, 00790 Helsinki, Finland.
          [4 ] 3Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
          [5 ] Fazer Group, Vantaa, Finland.
          [6 ] 5Clinic of Gastroenterology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
          Article
          278
          10.1186/s40795-019-0278-7
          7050854
          32153925
          414d38e5-2155-4e7d-9d3a-c7cbee89754f
          History

          Blautia,Diet,Bifidobacteria,Symptoms,Rye,Responder,Irritable bowel syndrome,Intestinal microbiota,IBS,FODMAP

          Comments

          Comment on this article

          Related Documents Log